SARAH MCGEE: Open Payments
NPI 1396521845 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,424 in 202 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $970 · 2025 $4,424
Food & beverage: $4,424
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $919 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $567 |
| Janssen Biotech, Inc. | 29 | $550 |
| Lilly USA, LLC | 11 | $311 |
| Madrigal Pharmaceuticals | 6 | $293 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $285 |
| Regeneron Healthcare Solutions, Inc. | 9 | $245 |
| Novo Nordisk Inc | 5 | $214 |
| Phathom Pharmaceuticals, Inc. | 12 | $199 |
| Ardelyx, Inc. | 9 | $176 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, RINVOQ, CREON, OMVOH, REZDIFFRA, XIFAXAN.
Industry payments across IN — which companies pay providers there.
